Log In
Print
BCIQ
Print
Print this Print this
 

ACH-3102

  Manage Alerts
Collapse Summary General Information
Company Achillion Pharmaceuticals Inc.
DescriptionPan-genotypic, second-generation HCV NS5A protein inhibitor
Molecular Target HCV NS5A protein
Mechanism of ActionHCV non-structural protein 5A inhibitor
Latest Stage of DevelopmentPhase II
IndicationHepatitis C virus (HCV)
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today